| Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition AN Hata, MJ Niederst, HL Archibald, M Gomez-Caraballo, FM Siddiqui, ... Nature medicine 22 (3), 262-269, 2016 | 963 | 2016 |
| Patient-derived models of acquired resistance can identify effective drug combinations for cancer AS Crystal, AT Shaw, LV Sequist, L Friboulet, MJ Niederst, EL Lockerman, ... Science 346 (6216), 1480-1486, 2014 | 806 | 2014 |
| KRAS G12C NSCLC models are sensitive to direct targeting of KRAS in combination with PI3K inhibition S Misale, JP Fatherree, E Cortez, C Li, S Bilton, D Timonina, DT Myers, ... Clinical Cancer Research 25 (2), 796-807, 2019 | 219 | 2019 |
| Genomic and functional fidelity of small cell lung cancer patient-derived xenografts BJ Drapkin, J George, CL Christensen, M Mino-Kenudson, R Dries, ... Cancer discovery 8 (5), 600-615, 2018 | 197 | 2018 |
| Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer AC Faber, AF Farago, C Costa, A Dastur, M Gomez-Caraballo, R Robbins, ... Proceedings of the National Academy of Sciences 112 (11), E1288-E1296, 2015 | 139 | 2015 |
| Exploitation of the apoptosis-primed state of MYCN-amplified neuroblastoma to develop a potent and specific targeted therapy combination J Ham, C Costa, R Sano, TL Lochmann, EM Sennott, NU Patel, A Dastur, ... Cancer cell 29 (2), 159-172, 2016 | 127 | 2016 |
| Programmed cell death ligand (PD-L1) expression in stage II and III lung adenocarcinomas and nodal metastases H Uruga, E Bozkurtlar, TG Huynh, A Muzikansky, Y Goto, ... Journal of Thoracic Oncology 12 (3), 458-466, 2017 | 124 | 2017 |
| Programmed cell death ligand 1 expression in resected lung adenocarcinomas: association with immune microenvironment TG Huynh, V Morales-Oyarvide, MJ Campo, JF Gainor, E Bozkurtlar, ... Journal of Thoracic Oncology 11 (11), 1869-1878, 2016 | 98 | 2016 |
| Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS-Mutant Non–Small Cell … V Nangia, FM Siddiqui, S Caenepeel, D Timonina, SJ Bilton, N Phan, ... Cancer discovery 8 (12), 1598-1613, 2018 | 91 | 2018 |
| Epithelial-to-mesenchymal transition antagonizes response to targeted therapies in lung cancer by suppressing BIM KA Song, MJ Niederst, TL Lochmann, AN Hata, H Kitai, J Ham, KV Floros, ... Clinical Cancer Research 24 (1), 197-208, 2018 | 90 | 2018 |
| Molecular taxonomy of human ocular outflow tissues defined by single-cell transcriptomics G Patel, W Fury, H Yang, M Gomez-Caraballo, Y Bai, T Yang, C Adler, ... Proceedings of the National Academy of Sciences 117 (23), 12856-12867, 2020 | 80 | 2020 |
| Therapy-induced APOBEC3A drives evolution of persistent cancer cells H Isozaki, R Sakhtemani, A Abbasi, N Nikpour, M Stanzione, S Oh, ... Nature 620 (7973), 393-401, 2023 | 53 | 2023 |
| Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers AN Hata, S Rowley, HL Archibald, M Gomez-Caraballo, FM Siddiqui, F Ji, ... Oncogene 36 (47), 6581-6591, 2017 | 38 | 2017 |
| A small molecule inhibitor of VE-PTP activates Tie2 in Schlemm's canal increasing outflow facility and reducing intraocular pressure G Li, AF Nottebaum, M Brigell, ID Navarro, U Ipe, S Mishra, ... Investigative ophthalmology & visual science 61 (14), 12-12, 2020 | 36 | 2020 |
| Integral role for lysyl oxidase-like-1 in conventional outflow tissue function and behavior G Li, H Schmitt, WM Johnson, C Lee, I Navarro, J Cui, T Fleming, ... FASEB journal: official publication of the Federation of American Societies …, 2020 | 27 | 2020 |
| APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancer H Isozaki, A Abbasi, N Nikpour, A Langenbucher, W Su, M Stanzione, ... BioRxiv, 2021.01. 20.426852, 2021 | 19 | 2021 |
| Physiologic consequences of caveolin-1 ablation in conventional outflow endothelia ML De Ieso, JM Gurley, ME McClellan, X Gu, I Navarro, G Li, ... Investigative ophthalmology & visual science 61 (11), 32-32, 2020 | 17 | 2020 |
| Identification and activity of the functional complex between hnRNPL and the pseudoexfoliation syndrome-associated lncRNA, LOXL1-AS1 HM Schmitt, WM Johnson, IF Aboobakar, S Strickland, ... Human Molecular Genetics 29 (12), 1986-1995, 2020 | 15 | 2020 |
| Combined targeting of MEK and MCL-1 induces apoptosis and tumor regression of KRAS mutant NSCLC AN Hata, FM Siddiqui, M Gomez-Caraballo, SJ Bilton, D Timonina, ... Cancer Research 77 (13_Supplement), 2163-2163, 2017 | 8 | 2017 |
| Impact and implication of fovea-involving intraretinal hemorrhage after acute branch retinal vein occlusion JH Powers, AS Thomas, TA Mir, JS Kim, FA Birnbaum, SP Yoon, K Khan, ... Ophthalmology Retina 3 (9), 760-766, 2019 | 7 | 2019 |
